Applying genomics to nutrition and lifestyle modification

Personalized Medicine

Volumn 9, Issue 7, 2012, Pages 739-749

  Nielsen, Daiva E ^a   El Sohemy, Ahmed ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

genetic testing; health behavior; nutrigenetics; nutrigenomics; personalized nutrition

Indexed keywords

ASCORBIC ACID;

ASCORBIC ACID DEFICIENCY; CHRONIC DISEASE; GENE DIET INTERACTION; GENE INTERACTION; GENETIC SCREENING; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; NUTRIGENOMICS; NUTRITION; PHENYLKETONURIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SALT SENSITIVE HYPERTENSION;

EID: 84866374297     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.12.79     Document Type: Review

References (97)

1. Ordovas JM. Genotype-phenotype associations: modulation by diet and obesity. Obesity (Silver Spring) 16(Suppl. 3), S40-S46 (2008).
2. Ordovas JM, Kaput J, Corella D. Nutrition in the genomics era: cardiovascular disease risk and the Mediterranean diet. Mol. Nut. Food Res. 51(10), 1293-1299 (2007).
3. Cahill LE, El-Sohemy A. Nutrigenomics: a possible road to personalized nutrition. In: Comprehensive Biotechnology (Volume 4, 2nd Edition). Moo-Young M (Ed.). Elsevier, Amsterdam, The Netherlands, 703-712 (2011).
4. El-Sohemy A. Nutrigenetics. Forum Nut. 60, 25-30 (2007).
5. Eny KM, El-Sohemy A. The genetic determinants of ingestive behaviour: sensory, energy homeostasis and food reward aspects of ingestive behaviour. In: Obesity Prevention: the Role of Brain and Society on Individual Behavior. Dube L, Bechara AD, Dagher A et al (Eds). Elsevier, London, UK, 149-160 (2010).
6. Garcia-Bailo B, Toguri C, Eny KM, El-Sohemy A. Genetic variation in taste and its influence on food selection. OMICS 13(1), 69-80 (2009).
7. Swallow DM. Genetics of lactase persistence and lactose intolerance. Annu. Rev. Genet. 37, 197-219 (2003).
8. Swagerty DL Jr, Walling AD, Klein RM. Lactose intolerance. Am. Fam. Physician 65(9), 1845-1850 (2002).
9. Dilella AG, Kwok SC, Ledley FD, Marvit J, Woo SL. Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene. Biochemistry 25(4), 743-749 (1986).
10. Surtees R, Blau N. The neurochemistry of phenylketonuria. Eur. J. Pediatr. 159(Suppl. 2), S109-S113 (2000).
11. National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference statement: phenylketonuria: screening and management. Pediatrics 108, 972-982 (2001).
12. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295(10), 1135-1141 (2006).
13. Palatini P, Ceolotto G, Ragazzo F et al. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J. Hypertens. 27(8), 1594-1601 (2009).
14. Cahill LE, Fontaine-Bisson B, El-Sohemy A. Functional genetic variants of glutathione S-transferase protect against serum ascorbic acid deficiency. Am. J. Clin. Nutr. 90(5), 1411-1417 (2009).
15. Paolisso G, D'amore A, Balbi V et al. Plasma vitamin C affects glucose homeostasis n healthy subjects and in non-insulin-dependent diabetics. Am. J. Physiol. 266(2 Pt 1), e261-e268 (1994).
16. Moran JP, Cohen L, Greene JM et al. Plasma ascorbic acid concentrations relate nversely to blood pressure in human subjects. Am. J. Clin. Nut. 57(2), 213-217 (1993).
17. Toohey L, Harris MA, Allen KG, Melby CL. Plasma ascorbic acid concentrations are related to cardiovascular risk factors in African-Americans. J. Nut. 126(1), 121-128 (1996).
18. Johnston CS, Dancho CL, Strong GM. Orange juice ingestion and supplemental vitamin C are equally effective at reducing plasma lipid peroxidation in healthy adult women. J. Am. Coll. Nut. 22(6), 519-523 (2003).
19. Ford ES, Liu S, Mannino DM, Giles WH, Smith SJ. C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur. J. Clin. Nut. 57(9), 1157-1163 (2003).
20. Canoy D, Wareham N, Welch A et al. Plasma ascorbic acid concentrations and fat distribution in 19,068 British men and women in the European Prospective Investigation into Cancer and Nutrition Norfolk cohort study. Am. J. Clin. Nutr. 82(6), 1203-1209 (2005).
21. Johnston CS, Beezhold BL, Mostow B, Swan PD. Plasma vitamin C is inversely related to body mass index and waist circumference but not to plasma adiponectin in nonsmoking adults. J. Nutr. 137(7), 1757-1762 (2007).
22. Reed DR, Knaapila A. Genetics of taste and smell poisons and pleasures. Prog. Mol. Biol. Transl Sci. 94, 213-240 (2010).
23. Eny KM, Wolever TM, Corey PN, El-Sohemy A. Genetic variation in TAS1R2 (Ile191Val) is associated with consumption of sugars in overweight and obese individuals in 2 distinct populations. Am. J. Clin. Nutr. 92(6), 1501-1510 (2010).
24. Giner V, Poch E, Bragulat E et al. Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension 35(1 Pt 2), 512-517 (2000).
25. Poch E, Gonzalez D, Giner V, Bragulat E, Coca A, De La Sierra A. Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 38(5), 1204-1209 (2001).
26. Corella D, Peloso G, Arnett DK et al. APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations. Arch. Intern. Med. 169(20), 1897-1906 (2009).
27. Cornelis MC, Qi L, Kraft P, Hu FB. TCF7L2, dietary carbohydrate, and risk of Type 2 diabetes in US women. Am. J. Clin. Nutr. 89(4), 1256-1262 (2009).
28. Ferguson JF, Phillips CM, McMonagle J et al. NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease, and interact with w-3 polyunsaturated fatty acids. Atherosclerosis 211(2), 539-544 (2010).
29. Solis C, Veenema K, Ivanov AA et al. Folate intake at RDA levels is inadequate for Mexican American men with the methylenetetrahydrofolate reductase 677TT genotype. J. Nutr. 138(1), 67-72 (2008).
30. Fontaine-Bisson B, Wolever TM, Connelly PW, Corey PN, El-Sohemy A. NF-kB-94Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations. Atherosclerosis 204(2), 465-470 (2009).
31. Eny KM, Wolever TM, Fontaine-Bisson B, El-Sohemy A. Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations. Physiol. Genomics 33(3), 355-360 (2008).
32. Eny KM, Corey PN, El-Sohemy A. Dopamine D2 receptor genotype (C957T) and habitual consumption of sugars in a free-living population of men and women. J. Nutrigenet. Nutrigenomics 2(4-5), 235-242 (2009).
33. Cornelis MC, El-Sohemy A, Campos H. GSTT1 genotype modifies the association between cruciferous vegetable intake and the risk of myocardial infarction. Am. J. Clin. Nutr. 86(3), 752-758 (2007).
34. Cuda C, Garcia-Bailo B, Karmali M, El-Sohemy A, Badawi A. A common polymorphism near the interleukin-6 gene modifies the association between dietary fat intake and insulin sensitivity. J. Inflamm. Res. 5, 1-6 (2012).
35. Ford D, Easton DF. The genetics of breast and ovarian cancer. Br. J. Cancer 72(4), 805-812 (1995).
36. Kinney AY, Simonsen SE, Baty BJ et al. Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred. J. Genet. Couns. 15(4), 293-305 (2006).
37. Watson M, Foster C, Eeles R et al. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br. J. Cancer 91(10), 1787-1794 (2004).
38. Claes E, Denayer L, Evers-Kiebooms G et al. Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. Genet. Test 9(1), 54-65 (2005).
39. Collins V, Meiser B, Gaff C, St John DJ, Halliday J. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer 104(2), 273-281 (2005).
40. Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J. Clin. Oncol. 22(1), 39-44 (2004).
41. Halbert CH, Lynch H, Lynch J et al. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch. Intern. Med. 164(17), 1881-1887 (2004).
42. Etzioni R, Urban N, Ramsey S et al. The case for early detection. Nat. Rev. Cancer 3(4), 243-252 (2003).
43. McBride CM, Bepler G, Lipkus IM et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol. Biomarkers Prev. 11(6), 521-528 (2002).
44. Sanderson SC, Humphries SE, Hubbart C, Hughes E, Jarvis MJ, Wardle J. Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a Phase II exploratory trial. J. Health Psychol. 13(4), 481-494 (2008).
45. McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 4(6), 589-594 (1995).
46. Bartsch H, Rojas M, Nair U, Nair J, Alexandrov K. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers. Cancer Detect Prev. 23(6), 445-453 (1999).
47. Hajek P, Stead LF, West R, Jarvis M, Lancaster T. Relapse prevention interventions for smoking cessation. Cochrane Database Syst. Rev. (1), CD003999 (2009).
48. Song F, Huttunen-Lenz M, Holland R. Effectiveness of complex psycho-educational interventions for smoking relapse prevention: an exploratory meta-analysis. J. Public Health (Oxf.). 32(3), 350-359 (2010).
49. Tonstad S, Tonnesen P, Hajek P et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 296(1), 64-71 (2006).
50. Conradt M, Dierk JM, Schlumberger P et al. A consultation with genetic information about obesity decreases self-blame about eating and leads to realistic weight loss goals in obese individuals. J. Psychosom. Res. 66(4), 287-295 (2009).
51. Rief W, Conradt M, Dierk JM et al. Is information on genetic determinants of obesity helpful or harmful for obese people?-a randomized clinical trial. J. Gen. Intern. Med. 22(11), 1553-1559 (2007).
52. Burk-Braxton CL. Is shame a factor in overweight relapse? Diss. Abstr. Int. B Sci. Eng. 57, 4052 (1996).
53. Arkadianos I, Valdes AM, Marinos E, Florou A, Gill RD, Grimaldi KA. Improved weight management using genetic information to personalize a calorie controlled diet. Nutr. J. 6, 29 (2007).
54. Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC. Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL Study. Alzheimer Dis. Assoc. Disord. 22(1), 94-97 (2008).
55. Marteau T, Senior V, Humphries SE et al. Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Am. J. Med. Genet. A 128A(3), 285-293 (2004).
56. Farrer LA, Cupples LA, Haines JL et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278(16), 1349-1356 (1997).
57. Green RC, Cupples LA, Go R et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA 287(3), 329-336 (2002).
58. Janssens AC, Van Duijn CM. An epidemiological perspective on the future of direct-to-consumer personal genome testing. Investig. Genet. 1(1), 10 (2010).
59. Sterling R. The on-line promotion and sale of nutrigenomic services. Genet. Med. 10(11), 784-796 (2008).
60. Norrgard K. DTC genetic testing for diabetes, breast cancer, heart disease and paternity. Nat. Educ. 1(1), (2008).
61. Burke W. Clinical validity and clinical utility of genetic tests. Curr. Protoc. Hum. Genet. Chapter 9, Unit 9.15 (2009).
62. Eng C, Sharp RR. Bioethical and clinical dilemmas of direct-to-consumer personal genomic testing: the problem of misattributed equivalence. Sci. Transl Med. 2(17), 17cm15 (2010).
63. Caulfield T, Ries NM, Ray PN, Shuman C, Wilson B. Direct-to-consumer genetic testing: good, bad or benign? Clin. Genet. 9(6-7), 48-50 (2010).
64. Janssens AC, Wilde AA, Van Langen IM. The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease. Neth. Heart J. 19(2), 85-88 (2011).
65. Mihaescu R, Van Hoek M, Sijbrands EJ et al. Evaluation of risk prediction updates from commercial genome-wide scans. Genet. Med. 11(8), 588-594 (2009).
66. Bloss CS, Darst BF, Topol EJ, Schork NJ. Direct-to-consumer personalized genomic testing. Hum. Mol. Genet. 20(R2), R132-R141 (2011).
67. McBride CM, Koehly LM, Sanderson SC, Kaphingst KA. The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annu. Rev. Public Health 31, 89-103 (2010).
68. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. N. Engl. J. Med. 364(6), 524-534 (2011).
69. Maher B. Nature readers flirt with personal genomics. Nature 478, 19 (2011).
70. Parekh S, Vandelanotte C, King D, Boyle FM. Design and baseline characteristics of the 10 Small Steps Study: a randomised controlled trial of an intervention to promote healthy behaviour using a lifestyle score and personalised feedback. BMC Public Health 12, 179 (2012).
71. Desroches S, Lapointe A, Ratte S, Gravel K, Legare F, Thirsk J. Interventions to enhance adherence to dietary advice for preventing and managing chronic diseases in adults: a study protocol. BMC Public Health 11, 111 (2011).
72. Jenab M, Slimani N, Bictash M, Ferrari P, Bingham SA. Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum. Genet. 125(5-6), 507-525 (2009).
73. Fuchs D, Winkelmann I, Johnson IT, Mariman E, Wenzel U, Daniel H. Proteomics in nutrition research: principles, technologies and applications. Br. J. Nutr. 94(3), 302-314 (2005).
74. Rezzi S, Ramadan Z, Fay LB, Kochhar S. Nutritional metabonomics: applications and perspectives. J. Proteome. Res. 6(2), 513-525 (2007).
75. Horska A, Mislanova C, Bonassi S, Ceppi M, Volkovova K, Dusinska M. Vitamin C levels in blood are influenced by polymorphisms in glutathione S-transferases. Eur. J. Nut. 50(6), 437-446 (2010).
76. Cahill LE, El-Sohemy A. Vitamin C transporter gene polymorphisms, dietary vitamin C and serum ascorbic acid. J. Nutrigenet. Nutrigenomics 2(6), 292-301 (2009).
77. Cahill LE, El-Sohemy A. Haptoglobin genotype modifies the association between dietary vitamin C and serum ascorbic acid deficiency. Am. J. Clin. Nut. 92(6), 1494-1500 (2010).
78. Fontaine-Bisson B, El-Sohemy A. Genetic polymorphisms of tumor necrosis factor-a modify the association between dietary polyunsaturated fatty acids and plasma high-density lipoprotein-cholesterol concentrations in a population of young adults. J. Nutrigenet. Nutrigenomics 1(5), 215-223 (2008).
79. Nielsen DE, El-Sohemy A. A randomized trial of genetic information for personalized nutrition. Genes. Nutr. doi:10.1007/s12263-012-0290-x (2012) (Epub ahead of print).
80. Nordgren A. Neither as harmful as feared by critics nor as empowering as promised by providers: risk information offered direct to consumer by personal genomics companies. J. Community Genet. doi:10.1007/s12687-012-0094-0 (2012) (Epub ahead of print).
81. Hawkins AK, Ho A. Genetic counseling and the ethical issues around direct to consumer genetic testing. J. Genet. Couns. 21(3), 367-373 (2012).
82. McGuire AL, Evans BJ, Caulfield T, Burke W. Science and regulation. Regulating direct-to-consumer personal genome testing. Science 330(6001), 181-182 (2010).
83. Leighton JW, Valverde K, Bernhardt BA. The general public's understanding and perception of direct-to-consumer genetic test results. Public Health Genomics 15(1), 11-21 (2011).
84. Lachance CR, Erby LA, Ford BM, Allen VC Jr, Kaphingst KA. Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers. Genet. Med. 12(5), 304-312 (2010).
85. Kaphingst KA, McBride CM, Wade C et al. Patients' understanding of and responses to multiplex genetic susceptibility test results. Genet. Med. doi:10.1038/gim.2012.22 (2012) (Epub ahead of print).
86. Stewart-Knox BJ, Bunting BP, Gilpin S et al. Attitudes toward genetic testing and personalised nutrition in a representative sample of European consumers. Br. J. Nutr. 101(7), 982-989 (2009).
87. Ronteltap A, Van Trijp JCM, Renes RJ. Consumer acceptance of nutrigenomics-based personalised nutrition. Br. J. Nutr. 101(1), 132-144 (2009).
88. Glanz K, Rimer, BK, Viswanath K. Theory, research, and practice in health behavior and health education. In: Health Behavior and Health Education: Theory Research and Practice (4th Edition). Glanz K, Rimer BK, Viswanath K (Eds). Jossey-Bass, CA, USA, 23-38 (2008).
89. Tavares LS, Plotnikoff RC, Loucaides C. Social-cognitive theories for predicting physical activity behaviours of employed women with and without young children. Psychol. Health Med. 14(2), 129-142 (2009).
90. Kirk A, De Feo P. Strategies to enhance compliance to physical activity for patients with insulin resistance. Appl. Physiol. Nutr. Metab. 32(3), 549-556 (2007).
91. Baker R, Reddish S, Robertson N, Hearnshaw H, Jones B. Randomised controlled trial of tailored strategies to implement guidelines for the management of patients with depression in general practice. Br. J. Gen. Pract. 51(470), 737-741 (2001).
92. Webb TL, Sniehotta FF, Michie S. Using theories of behaviour change to inform interventions for addictive behaviours. Addiction 105(11), 1879-1892 (2010).
93. Horwath CC. Applying the transtheoretical model to eating behaviour change: challenges and opportunities. Nutr. Res. Rev. 12(2), 281-317 (1999).
94. Anderson AS. How to implement dietary changes to prevent the development of metabolic syndrome. Br. J. Nutr. 83(Suppl. 1), S165-S168 (2000).
95. Green ED, Guyer MS. Charting a course for genomic medicine from base pairs to bedside. Nature 470(7333), 204-213 (2011).
96. Stice E, Dagher A. Genetic variation in dopaminergic reward in humans. Forum Nut. 63, 176-185 (2010).
97. McBride CM, Bryan AD, Bray MS, Swan GE, Green ED. Health behavior change: can genomics improve behavioral adherence? Am. J. Public Health 102(3), 401-405 (2012).